Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America).
about
Increasing ciprofloxacin resistance among prevalent urinary tract bacterial isolates in Gaza Strip, Palestine.MrkH, a novel c-di-GMP-dependent transcriptional activator, controls Klebsiella pneumoniae biofilm formation by regulating type 3 fimbriae expressionVirulence characteristics and genetic affinities of multiple drug resistant uropathogenic Escherichia coli from a semi urban locality in IndiaUrinary tract infections during pregnancy.Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location.Rapid detection of urinary tract pathogens using microcalorimetry: principle, technique and first results.The TIR Domain Containing Locus of Enterococcus faecalis Is Predominant among Urinary Tract Infection Isolates and Downregulates Host Inflammatory Response.Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United StatesThe magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported.Laboratory diagnosis of urinary tract infections in adult patients.In vitro activity of ceftazidime combined with NXL104 versus Pseudomonas aeruginosa isolates obtained from patients in Canadian hospitals (CANWARD 2009 study).Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study.Demographic features and antibiotic resistance among children hospitalized for urinary tract infection in northwest Iran.Aminoglycoside resistance in Pseudomonas aeruginosa.Emerging drugs for bacterial urinary tract infections.A retrospective study of the changing trends of antimicrobial resistance of Klebsiella pneumoniae isolated from urine samples over last 3 years (2012-2014)Importance of the epa locus of Enterococcus faecalis OG1RF in a mouse model of ascending urinary tract infection.Fluoroquinolone and Third-Generation-Cephalosporin Resistance among Hospitalized Patients with Urinary Tract Infections Due to Escherichia coli: Do Rates Vary by Hospital Characteristics and Geographic Region?Cefepime: a reappraisal in an era of increasing antimicrobial resistance.In vitro activity of ceftolozane-tazobactam against Pseudomonas aeruginosa isolates obtained from patients in Canadian hospitals in the CANWARD study, 2007 to 2012.Transcriptional activation of the mrkA promoter of the Klebsiella pneumoniae type 3 fimbrial operon by the c-di-GMP-dependent MrkH protein.Variety of beta-lactamases produced by amoxicillin-clavulanate-resistant Escherichia coli isolated in the northeastern United States.Epidemiology, treatment and prevention of healthcare-associated urinary tract infections.Gastrointestinal Carriage Is a Major Reservoir of Klebsiella pneumoniae Infection in Intensive Care Patients.Overcoming β-lactam resistance in Gram-negative pathogens.Complicated urinary tract infection caused by Pseudomonas aeruginosa in a single institution (1999-2003).Are first-generation cephalosporins obsolete? A retrospective, non-inferiority, cohort study comparing empirical therapy with cefazolin versus ceftriaxone for acute pyelonephritis in hospitalized patients.Temporal interplay between efflux pumps and target mutations in development of antibiotic resistance in Escherichia coli.Retrospective analysis of antibiotic resistance pattern to urinary pathogens in a Tertiary Care Hospital in South India.In vitro antibacterial activity of DX-619, a novel des-fluoro(6) quinolone.Species distribution and antibiotic susceptibility profile of bacterial uropathogens among patients complaining urinary tract infections.Efficacy and safety of ciprofloxacin XR 1000 mg once daily versus ciprofloxacin 500 mg twice daily in the treatment of complicated urinary tract infections.Antibiotic resistance of uropathogens isolated from Al-Shifa hospital in Gaza Strip in 2002.Susceptibility of Escherichia coli to L-selenaproline and other L-proline analogues in laboratory culture media and normal human urine.Blood culture and susceptibility results and allergy history do not influence fluoroquinolone use in the treatment of community-acquired pneumonia.A 6-year study of complicated urinary tract infections in southern China: prevalence, antibiotic resistance, clinical and economic outcomes.Healthcare-associated urinary tract infections in hospitalized urological patients--a global perspective: results from the GPIU studies 2003-2010.Change in antimicrobial susceptibility of Escherichia coli urinary tract isolates at a single institution over a period of 10 years.Prevalence of Multidrug Resistance and Extended-Spectrum -Lactamase Carriage of Clinical Uropathogenic Isolates in Riyadh, Saudi Arabia
P2860
Q24815306-7B93D9F4-633D-4DAD-B3EB-4DD81C379C0AQ28476704-65F71A45-F50F-45C1-BFD1-3C33F1270DCCQ28477517-C00F243E-938E-494D-9F7D-AE6AF0D679D8Q33206285-100CC5E6-4E69-45ED-BAA6-2C271A95DC8BQ33314977-F75ED3A9-7641-4EEB-BC1E-786E9D310C65Q34030592-6697E5BD-726D-4646-85AD-D9D17F77E55DQ34039552-51D6631D-029C-4228-9A5E-D969AC46F8CFQ34110686-31FFCC43-FD82-4525-9E8B-6DECB277178BQ34141233-BE5863C4-5BC1-44CE-ABB2-96458030F22CQ34547218-D84E9BCE-5806-4A71-9ABC-E7159F4E485BQ35004966-ECD94F35-86A1-4A64-A59A-6BA1FEE6FAA5Q35065834-D72522CB-D87A-4A8E-8595-50B09231BDD6Q35547763-66493358-4DC5-4514-81D1-3AA08DD9EF86Q36021296-475C7BE2-0D14-43F0-92AC-AAA640E392DBQ36150606-26734CDE-3CE6-4C37-ABC8-934A8731BD39Q36657443-35006FCF-6E92-42A0-AF7C-A99522ED776AQ36738012-FA36471B-DFCB-45D6-9EF6-D5836032F1E9Q36887826-C5B208D2-8D81-466D-BBF7-84AC317B8CCFQ37079350-52A31993-184C-4A4D-BFFB-1AE35B17B9E0Q37263317-31CB5C1C-46A1-4790-82A2-99EB5582A276Q37309122-7E154D08-6B64-47B8-B756-8F40419059F3Q37734137-47A9E7DB-6148-41E0-A6E1-2B7A61D52AC3Q37928501-C0D992E4-69CA-469F-B0D7-66FBF02374D0Q38860335-492C21CC-4F88-4CC2-BBC5-99129E19BD6DQ38862139-3C0F0394-8A18-465D-B1F6-0FF3FE5BD9F0Q40476883-D8F55723-4B9C-4F3D-AF37-9D9253E437C9Q40752693-65B50F9A-3451-4B3E-A83C-195DC0702C83Q41788804-46DCA829-3D70-420F-BD35-8CDBF574E01BQ41828225-00122BC7-1288-4A8E-BBBB-FFD39D17AA43Q42112686-E00B853C-587E-4B0B-BCFD-8DB651194603Q42221011-5A8930A0-398B-433A-9079-CA8C19841575Q43195355-87C9470C-B4C7-48AF-B09B-3DC53626B8D2Q43693445-6F8084F4-9A4F-4659-9907-94DD6EB40356Q45046000-38A135DC-5366-4973-AECE-1891DD9569E6Q45936465-95361C00-0ABA-4122-8BE9-93982295D231Q47157609-B6836F40-2821-4E92-A563-7535EF31A5A6Q51237319-97706963-12A4-4CC1-AC4D-56326B0F6532Q53655188-BE7B3BEB-88FE-4394-AFA2-5242A4E68744Q57300295-1367E354-900D-4AA4-AF32-BEB8D79A335B
P2860
Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America).
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Epidemiology and frequency of ...... lance Program (North America).
@en
Epidemiology and frequency of ...... lance Program (North America).
@nl
type
label
Epidemiology and frequency of ...... lance Program (North America).
@en
Epidemiology and frequency of ...... lance Program (North America).
@nl
prefLabel
Epidemiology and frequency of ...... lance Program (North America).
@en
Epidemiology and frequency of ...... lance Program (North America).
@nl
P2093
P1476
Epidemiology and frequency of ...... lance Program (North America).
@en
P2093
M A Pfaller
SENTRY Participant Group North America
P304
P356
10.1016/S0732-8893(01)00254-1
P577
2001-07-01T00:00:00Z